AYTU vs. JBL
AYTU (Aytu BioPharma, Inc.) and JBL (Jabil Inc.) are both stocks. AYTU operates in Drug Manufacturers - Specialty & Generic (Healthcare), while JBL operates in Electronic Components (Technology). Over the past 5 years, AYTU returned -53.73%/yr vs 45.20%/yr for JBL. At a 0.16 correlation, their price movements are largely independent.
Performance
AYTU vs. JBL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AYTU achieves a -11.92% return, which is significantly lower than JBL's 59.70% return.
AYTU
- 1D
- 1.78%
- 1M
- -8.40%
- YTD
- -11.92%
- 6M
- 2.23%
- 1Y
- 14.50%
- 3Y*
- 12.70%
- 5Y*
- -53.73%
- 10Y*
- —
JBL
- 1D
- 3.03%
- 1M
- 2.50%
- YTD
- 59.70%
- 6M
- 61.54%
- 1Y
- 106.33%
- 3Y*
- 57.02%
- 5Y*
- 45.20%
- 10Y*
- 35.40%
AYTU vs. JBL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AYTU Aytu BioPharma, Inc. | -11.92% | 52.94% | -40.14% | -24.87% | -86.00% | -77.42% | -38.35% | 22.41% | -98.22% | -88.85% |
JBL Jabil Inc. | 59.70% | 58.73% | 13.25% | 87.43% | -2.55% | 66.40% | 3.89% | 68.49% | -4.41% | 9.49% |
Correlation
The correlation between AYTU and JBL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Feb 2, 2017 | 0.16 |
Fundamentals
AYTU:
$24.07M
JBL:
$39.16B
AYTU:
-$2.91
JBL:
$7.47
AYTU:
0.47
JBL:
1.21
AYTU:
0.68
JBL:
29.14
AYTU:
$56.60M
JBL:
$32.67B
AYTU:
$36.14M
JBL:
$2.95B
AYTU:
-$27.34M
JBL:
$1.55B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AYTU vs. JBL — Risk / Return Rank
AYTU
JBL
AYTU vs. JBL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Jabil Inc. (JBL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AYTU | JBL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.30 | ||
| Sortino ratioReturn per unit of downside risk | -2.19 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.39 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 0.41 | 5.99 | -5.58 |
| Martin ratioReturn relative to average drawdown | 0.97 | 15.50 | -14.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AYTU | JBL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.27 | 2.56 | -2.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.63 | 1.20 | -1.83 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.96 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.36 | 0.37 | -0.73 |
Drawdowns
AYTU vs. JBL - Drawdown Comparison
The maximum AYTU drawdown since its inception was -100.00%, which is greater than JBL's maximum drawdown of -94.92%. Use the drawdown chart below to compare losses from any high point for AYTU and JBL.
Loading charts...
Drawdown Indicators
| AYTU | JBL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -94.92% | -5.08% |
Max Drawdown (1Y)Largest decline over 1 year | -35.47% | -17.86% | -17.61% |
Max Drawdown (3Y)Largest decline over 3 years | -70.24% | -36.83% | -33.41% |
Max Drawdown (5Y)Largest decline over 5 years | -99.12% | -36.83% | -62.29% |
Max Drawdown (10Y)Largest decline over 10 years | — | -57.34% | — |
Current DrawdownCurrent decline from peak | -100.00% | -4.29% | -95.71% |
Average DrawdownAverage peak-to-trough decline | -95.15% | -44.52% | -50.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.92% | 6.89% | +8.03% |
Volatility
AYTU vs. JBL - Volatility Comparison
Aytu BioPharma, Inc. (AYTU) has a higher volatility of 14.09% compared to Jabil Inc. (JBL) at 13.15%. This indicates that AYTU's price experiences larger fluctuations and is considered to be riskier than JBL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AYTU | JBL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.09% | 13.15% | +0.94% |
Volatility (6M)Calculated over the trailing 6-month period | 33.39% | 32.41% | +0.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.06% | 41.78% | +13.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.66% | 37.80% | +47.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 188.20% | 37.12% | +151.08% |
Dividends
AYTU vs. JBL - Dividend Comparison
AYTU has not paid dividends to shareholders, while JBL's dividend yield for the trailing twelve months is around 0.09%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AYTU Aytu BioPharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JBL Jabil Inc. | 0.09% | 0.14% | 0.22% | 0.25% | 0.47% | 0.45% | 0.75% | 0.77% | 1.29% | 1.22% | 1.35% | 1.37% |
Financials
AYTU vs. JBL - Financials Comparison
This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Jabil Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AYTU vs. JBL - Profitability Comparison
AYTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.
JBL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Jabil Inc. reported a gross profit of 746.00M and revenue of 8.28B. Therefore, the gross margin over that period was 9.0%.
AYTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.
JBL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Jabil Inc. reported an operating income of 374.00M and revenue of 8.28B, resulting in an operating margin of 4.5%.
AYTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.
JBL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Jabil Inc. reported a net income of 223.00M and revenue of 8.28B, resulting in a net margin of 2.7%.
Frequently Asked Questions
AYTU and JBL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AYTU has higher volatility (14.09%) compared to JBL (13.15%). In terms of maximum drawdown, AYTU dropped -100.00% vs JBL's -94.92%.
JBL currently has the higher Sharpe Ratio (2.56 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AYTU and JBL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer